Surprisingly, IL-22 overexpression, either by IL-22 transgenic mice or exogenous administration of adenovirus expressing IL-22, is able to reduce hepatic fibrosis and accelerate the resolution of liver fibrosis during recovery 59. The gene discussed is IL22; the disease is Hepatic fibrosis.